Company Performance Metrics
Théa Holding is a pharmaceutical group that focuses on the research, development, production, and commercialization of ophthalmic treatments and eye care products. The company operates through subsidiaries such as Laboratoires Théa, which develops preservative-free eye drops, ocular hygiene products, nutritional supplements, and treatments for
conditions including glaucoma, dry eye, allergies, infections, and inflammation. Théa Holding supports clinical programs and partnerships in areas such as myopia progression, autoimmune-associated dry eye disease, and inherited retinal disorders. Its portfolio includes proprietary delivery systems and a range of prescription and over-the-counter eye care solutions distributed through healthcare professionals and pharmacies. The group also invests in collaborations with biotechnology companies to expand its pipeline of therapies for anterior and posterior segment eye diseases.
